CIK 0001590877
- Non-accelerated filer
- Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 471851754
- Phone
- +1 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-10-15 | Vasista Vittal Chief Financial Officer | Sale | −5,000 | $59.59 | $298K | 137,283 |
| 2018-10-15 | Mills Kenneth T. President and CEO | Sale | −1,800 | $58.73 | $106K | 331,710 |
| 2018-10-15 | Mills Kenneth T. President and CEO | Sale | −5,710 | $59.55 | $340K | 326,000 |
| 2018-10-08 | Danos Olivier Chief Scientific Officer | Exercise or conversion | +20,000 | $20.35 | $407K | 20,000 |
| 2018-10-08 | Danos Olivier Chief Scientific Officer | Sale | −3,500 | $62.79 | $220K | 16,500 |
| 2018-10-08 | Danos Olivier Chief Scientific Officer | Sale | −12,284 | $63.73 | $783K | 4,216 |
| 2018-10-08 | Danos Olivier Chief Scientific Officer | Sale | −4,000 | $64.78 | $259K | 216 |
| 2018-10-08 | Danos Olivier Chief Scientific Officer | Sale | −216 | $65.60 | $14K | 0 |
| 2018-10-08 | Danos Olivier Chief Scientific Officer | Exercise or conversion · Stock Option (Right to Buy) | −20,000 | 80,000 | ||
| 2018-09-17 | Vasista Vittal Chief Financial Officer | Sale | −1,561 | $70.43 | $110K | 120,722 |
| 2018-09-17 | Vasista Vittal Chief Financial Officer | Sale | −200 | $72.03 | $14K | 120,522 |
| 2018-09-17 | Vasista Vittal Chief Financial Officer | Sale | −1,200 | $73.40 | $88K | 119,322 |
| 2018-09-17 | Vasista Vittal Chief Financial Officer | Sale | −710 | $74.02 | $53K | 118,612 |
| 2018-09-17 | Vasista Vittal Chief Financial Officer | Sale | −700 | $75.59 | $53K | 117,912 |
| 2018-09-17 | Vasista Vittal Chief Financial Officer | Sale | −1,479 | $76.79 | $114K | 116,433 |
| 2018-09-17 | Vasista Vittal Chief Financial Officer | Sale | −600 | $77.87 | $47K | 115,833 |
| 2018-09-17 | Vasista Vittal Chief Financial Officer | Sale | −450 | $78.64 | $35K | 115,383 |
| 2018-09-17 | Vasista Vittal Chief Financial Officer | Sale | −500 | $79.63 | $40K | 114,883 |
| 2018-09-17 | Vasista Vittal Chief Financial Officer | Sale | −100 | $80.80 | $8K | 114,783 |
| 2018-09-17 | Vasista Vittal Chief Financial Officer | Exercise or conversion | +30,000 | $0.85 | $26K | 144,783 |
Page 38 of 43 · 852 trades